Kezar Life Sciences
75 hedge funds and large institutions have $150M invested in Kezar Life Sciences in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
5% less capital invested
Capital invested by funds: $158M → $150M (-$7.87M)
10% less funds holding
Funds holding: 83 → 75 (-8)
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Holders
75
Holding in Top 10
2
Calls
$34K
Puts
$10K
Top Buyers
| 1 | +$8.51M | |
| 2 | +$8.14M | |
| 3 | +$4.19M | |
| 4 |
O
OrbiMed
New York
|
+$3.03M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
+$1.48M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$8.03M | |
| 3 | -$2.93M | |
| 4 |
Two Sigma Investments
New York
|
-$495K |
| 5 |
VEA
Virtus ETF Advisers
New York
|
-$324K |